Board Issues Conditional Approval to Five Pharmaceutical Processors. Read more
CBD Oil and THC-A Oil Registration Applications for Patients, Parents/Legal Guardians, and Physicians Now Available
The law provides for an affirmative defense for a patient, parent or legal guardian to possess cannabidiol (CBD) oil or THC-A oil, as defined in §54.1-3408.3 of the Code of Virginia who has been issued a valid written certification from a Board of Pharmacy-registered physician and who maintains a current registration with the Board of Pharmacy.
Before a physician can issue or continue issuing written certifications, he or she must register with the Board of Pharmacy. Learn More about Physician Registration.
A patient, parent or legal guardian must have a written certification issued to them by a Physician prior to applying for registration with the Board of Pharmacy and possessing the oils. Learn More about Patient/Parent/Guardian Registration.
A pharmaceutical processor is a facility that has obtained a permit from the Board of Pharmacy pursuant to § 54.1-3408.3 to cultivate Cannabis plants for the production of cannabidiol oil or THC-A oil, and dispense the oil to patients registered by the Board of Pharmacy for treatment or to alleviate the symptoms of any diagnosed condition or disease determined by the physician to benefit from such use. As set forth in §54.1-3442.6 of the Code of Virginia, the Board may issue or renew in any year a maximum of 5 permits, one for each health service area established by the Board of Health. The application process for pharmaceutical processor permits will occur in three stages: submission of initial application, awarding of conditional approval, and granting of a pharmaceutical processor permit.
As of April 16, 2018, a Request for Application (RFA) process has opened for obtaining conditional approval for a pharmaceutical processor permit. For consideration, a complete application, required documentation, and the nonrefundable application fee of $10,000 must be received no later than 2pm on June 8, 2018. The RFA may be downloaded here.
NOTE: To provide sufficient time for the ad hoc committee to complete a thorough evaluation of the pharmaceutical processor applications, the tentative schedule referenced in the RFA has been amended as follows:
• September 4-5, 2018 - In-person meeting for ad hoc committee to discuss scoring of applicants
• September 25, 2018 - Board reviews scoring and identifies which Applicants will be awarded conditional approval
• October 9, 2018 - Deadline for fingerprinting and submission of information for criminal background checks
• November 28, 2018 -The Board will review results of the criminal background checks and finalize awarding of conditional approvals